Showing results (1111-1120 of 6,754) with videos related to
Sort By:
Pageof 676
European Journal of Endocrinology|March 1, 1995
Missense mutation in CYP11B1 (CGA[Arg-384]-->GGA[Gly]) causes steroid 11 beta-hydroxylase deficiencyY Nakagawa, M Yamada, H Ogawa, et al.European Journal of Endocrinology|March 1, 1995
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenomaR Rossi, S Savastano, A P Tommaselli, et al.European Journal of Endocrinology|March 1, 1995
Dexamethasone therapy is associated with a rise in urinary epidermal growth factor concentrations in the preterm infantS M Scott, C Rogers, C BackstromEuropean Journal of Endocrinology|March 1, 1995
Lack of evidence for pituitary thyrotroph down-regulation after 1 week of oral thyrotrophin-releasing hormone and metoclopramide under conditions of constant peripheral thyroid hormone levelsS K Grebe, J W Delahunt, C M Feek, et al.European Journal of Endocrinology|May 1, 2002
Genetic analysis of lithium-associated parathyroid tumorsT Dwight, S Kytölä, B T Teh, et al.European Journal of Endocrinology|May 1, 2002
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetesMichele Dalla Vestra, David Sacerdoti, Giancarlo Bombonato, et al.European Journal of Endocrinology|March 13, 2002
The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitorSanna Wickman, Tero Saukkonen, Leo DunkelEuropean Journal of Endocrinology|March 13, 2002
Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitusHajime Ueshiba, Yusuke Shimizu, Naoki Hiroi, et al.European Journal of Endocrinology|January 1, 1995
Augmentation of thyrotropin-induced iodide uptake in FRTL-5 cells by immunoglobulins containing blocking thyrotropin-receptor antibodies under NaCl-depleted conditionsR Takeuchi, K Kasagi, A Hidaka, et al.European Journal of Endocrinology|January 1, 1995
Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal agingE Ghigo, G P Ceda, R Valcavi, et al.Pageof 676